3 years ago

Development of an in vitro biopotency assay for an AAV8 hemophilia B gene therapy vector suitable for clinical product release

Development of an <em>in vitro</em> biopotency assay for an AAV8 hemophilia B gene therapy vector suitable for clinical product release
Johannes Lengler, Sogue Coulibaly, Bernadette Gruber, Reinhard Ilk, Josef Mayrhofer, Friedrich Scheiflinger, Werner Hoellriegl, Falko G. Falkner, Hanspeter Rottensteiner

Gene therapy product release requires reliable and consistent demonstration of biopotency. In hemophilia B vectors, this is usually determined in vivo by measuring the plasma levels of the expressed human FIX transgene product in factor IX (FIX) knockout mice. To circumvent this laborious assay, an in vitro method was developed in which the HepG2 human liver cell line was infected with the vector, and the resulting FIX activity determined in the conditioned medium using a chromogenic assay. The initial low sensitivity of the assay, particularly toward AAV8, increased approximately 100-fold and allowed linear measurement in a broad range of multiplicities of infection. Statistical parameters indicated high assay repeatability (relative standard deviation (RSD) <5%) and intra-assay reproducibility (RSD <20%). To compare the performance of the in vitro and in vivo biopotency assay, statistical analyses including regression techniques and variation decomposition were applied to the results obtained for 25 AAV8-FIX vector lots (BAX 335). These showed a highly significant correlation, with the cell culture-based assay demonstrating less variation than the in vivo test. The in vitro assay thus constitutes a viable alternative to using animals for lot release testing.

Open access
You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.